BMI1 was first identified as an oncogenic effector for the development of lymphocytic leukemia by suppressing c-Myc, which is dysregulated in multiple cancer types, such as colon, lung and liver cancers [225,226,227]. The gene discussed is BMI1; the disease is cancer.